Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria
PHASE2CompletedINTERVENTIONAL
Enrollment
50
Participants
Timeline
Start Date
November 30, 2007
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
Conditions
HypertensionType II Diabetes Mellitus
Interventions
DRUG
SPP635
oral once daily
Trial Locations (1)
Unknown
Dr. John Barton, Ballinasloe
All Listed Sponsors
lead
Speedel Pharma Ltd.
INDUSTRY
NCT00561171 - Phase IIa Study to Investigate the Efficacy and Safety of SPP635 in Diabetic and Hypertensive Patients With Albuminuria | Biotech Hunter | Biotech Hunter